Allarity Therapeutics, Inc. Adjustments to Additional Paid in Capital, Fair Value
Allarity Therapeutics, Inc. (ALLR) reported Adjustments to Additional Paid in Capital, Fair Value of -$6.25 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2024-03-08
- Allarity Therapeutics, Inc. adjustments to additional paid in capital, fair value for fiscal 2023 was -$6.25M.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 12 month |
|---|---|
| 2023-12-31 | -$6.25M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |